表紙:中国の精神疾患治療薬市場
市場調査レポート
商品コード
81740

中国の精神疾患治療薬市場

Mental Illness Drugs Markets in China

出版日: | 発行: Asia Market Information & Development Co. | ページ情報: 英文 251 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.08円
中国の精神疾患治療薬市場
出版日: 2023年11月27日
発行: Asia Market Information & Development Co.
ページ情報: 英文 251 Pages
納期: 即納可能 即納可能とは
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

中国の精神疾患治療薬の需要は過去10年間に急速なペースで拡大してきました。今後10年間は、製造、需要ともに拡大が続くものと思われます。中国経済は、20年以上にわたる工業製造高、輸出入、消費、設備投資の連続的な増加に刺激され、高速成長を維持しています。

当レポートでは、中国の精神疾患治療薬の市場を調査し、中国の経済動向・事業環境、産業構造、需給動向、市場規模と成長の見通し、マーケティング戦略、主要製造業者のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 事業環境

  • 経済見通し
  • 主要経済指標
  • 工業製造
  • 人口と労働力
  • 外国投資
  • 外国貿易
  • 財務および税に関する規制
  • 銀行システムと規制
  • 外国為替
  • 税金・関税・通関手続き

第3章 精神疾患治療薬産業の評価

  • 精神疾患治療薬産業の構造
  • 市場規模
  • 市場促進要因
  • 精神疾患治療薬の販売規模
  • 主な製造施設の所在地・販売規模
  • 主要製造業者の市場シェア
  • 人件費
  • 潜在的参入企業
  • 主な販売代理店
  • 主な外国投資
  • 技術開発

第4章 精神疾患治療薬の製造・需要

  • 概要
  • 医薬品の販売規模:地域別
  • 精神疾患治療薬の販売規模
  • Haloperido
  • Chlorpromazine
  • Ziprasidone
  • Olanzapine
  • Clozapine
  • Quetiapine
  • Aripiprazole
  • Risperidone
  • Fluoxetine
  • その他の精神疾患治療薬
  • 精神疾患治療薬の輸出入
  • 精神疾患治療薬の輸入
  • 精神疾患治療薬の輸出
  • 価格動向

第5章 中国の精神疾患治療薬市場の見通し

  • 精神疾患治療薬市場の見通し:概要
  • 政府の規制
  • 医療保険産業の概要
  • 消費動向
  • 人口動態の動向
  • ヘルスケア産業の動向
  • 病院・病床数
  • 医師・医師訪問数

第6章 市場参入経路

  • 中国市場への参入の概要
  • 中国の流通システム
  • ゴム加工薬品の流通経路
  • 輸送および貨物インフラ
  • コミュニケーション
  • 中国の市場参入
  • ライセンシング
  • フランチャイズ
  • eコマース
  • 商社・現地代理店
  • 駐在員事務所・中国子会社
  • 100%外資系企業

第7章 精神疾患治療薬製造業者のディレクトリー

  • 精神疾患治療薬製造業者のプロファイル・ディレクトリー
  • 主なエンドユーザー
図表

LIST OF TABLES

I. INTRODUCTION

  • Economic Outlook Summary

II. BUSINESS ENVIRONMENT

  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade

III. MENTAL ILLNESS DRUGS INDUSTRY ASSESSMENTS

  • Mental Illness Drugs Sales Volume
  • Major Producer Facility Location
  • Major Mental Illness Drugs Producer Sales Volume
  • Market Share of Key Producers
  • Major Foreign Investment in China

IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND

  • Mental Illness Drugs Sales Volume
  • Demand of Mental Illness Drugs by Region
  • Haloperido Sales Volume
  • Chlorpromazine Sales Volume
  • Ziprasidone Sales Volume
  • Olanzapine Sales Volume
  • Clozapine Sales Volume
  • Quetiapine Sales Volume
  • Aripiprazole Sales Volume
  • Risperidone Sales Volume
  • Fluoxetine Sales Volume
  • Other Mental Illness Drugs Sales Volume
  • China Mental Illness Drugs Imports and Exports

V. CHINA MENTAL ILLNESS DRUGS MARKETS OUTLOOK

  • Total Mental Illness Drugs Sales Volume by Market
  • Consumer Spending Trend
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
  • Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

  • China's Mental Illness Drugs Output, Capacity, Demand

II. BUSINESS ENVIRONMENT

  • China's GDP and Growth Rate
  • Industrial Output by Ownership
  • China's Imports and Exports

III. MENTAL ILLNESS DRUGS INDUSTRY ASSESSMENTS

  • Mental Illness Drugs Sales Volume in China

IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND

  • Mental Illness Drugs Sales Volume in China
  • Haloperido Sales Volume
  • Chlorpromazine Sales Volume
  • Ziprasidone Sales Volume
  • Olanzapine Sales Volume
  • Clozapine Sales Volume
  • Quetiapine Sales Volume
  • Aripiprazole Sales Volume
  • Risperidone Sales Volume
  • Fluoxetine Sales Volume
  • Total Mental Illness Drugs Imports and Exports

V. MENTAL ILLNESS DRUGS MARKETS OUTLOOK

  • Mental Illness Drugs Sales Volume by Market

VI. MARKETING STRATEGIES

  • China's Distribution Channel
目次
Product Code: 809

China's demand for Mental Illness Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2012, 2017 and 2022) and long-term forecasts through 2027 and 2032 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments' industry bureaus, industry publications, and our in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Our market research reports provide hard-to-find market data and analyses. Today, China has the largest market in the world. Tremendous fast-growing markets for imports and business opportunities for companies around the world. If you want to expand your business or sell your products in China, our research reports provide the insights and projections into Chinese markets necessary for you to do so.

TABLE OF CONTENTS

I. INTRODUCTION

  • Report Scope and Methodology
  • Executive Summary

II. BUSINESS ENVIRONMENT

  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties

III. MENTAL ILLNESS DRUGS INDUSTRY ASSESSMENTS

  • Mental Illness Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Mental Illness Drugs Sales Volume
  • Major Producer Facility Locations and Sales Volume
  • Market Share of Key Producers
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development

IV. MENTAL ILLNESS DRUGS PRODUCTION AND DEMAND

  • Overview
  • Sales Volume of Pharmaceuticals by Region
  • Mental Illness Drugs Sales Volume
  • Haloperido
  • Chlorpromazine
  • Ziprasidone
  • Olanzapine
  • Clozapine
  • Quetiapine
  • Aripiprazole
  • Risperidone
  • Fluoxetine
  • Other Mental Illness Drugs
  • Mental Illness Imports and Exports
  • Mental Illness Drugs Imports
  • Mental Illness Exports
  • Pricing Trend

V. CHINA MENTAL ILLNESS DRUGS MARKETS OUTLOOK

  • Mental Illness Drugs Market Outlook Overview
  • Government Regulation
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospitals Beds
  • Physicians and Physician Visits

VI. MARKET ENTRY CHANNELS

  • China Market Entry Overview
  • China's Distribution System
  • Rubber Processing Chemicals Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China's Market Entry
  • Licensing
  • Franchising
  • E-commerce
  • Trading Companies and Local Agents
  • Representative Offices and Chinese Subsidiaries
  • Wholly Foreign Owned Enterprises

VII. MENTAL ILLNESS DRUGS PRODUCER DIRECTORY

  • Mental Illness Drugs Producer Profiles and Directory
  • Major End-Users